Results 71 to 80 of about 277,449 (338)
Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence [PDF]
, 2018 Background: Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B indicated to prevent C. difficile infection (CDI) recurrence (rCDI) in adults at high risk for rCDI. This post hoc analysis of pooled monocolonal antibodies for
Dorr, Mary Beth +12 more
core +2 more sources
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT Aim The prognostic immune nutritional index (PINI) is increasingly recognized for its potential clinical utility. However, multifaceted evaluations of its ability to predict oncological outcomes in colorectal cancer (CRC) and its association with postoperative infectious complications remain limited.
Shinji Yamashita +9 more
wiley +1 more source
Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
Journal of Immunology Research, 2014 Recurrent Clostridium difficile infection represents a burdensome clinical issue whose epidemiology is increasing worldwide. The pathogenesis is not yet completely known.
Stefano Bibbò +5 more
doaj +1 more source
Clostridium difficile – From Colonization to Infection
Frontiers in Microbiology, 2018 Clostridium difficile is the most frequent cause of nosocomial antibiotic-associated diarrhea. The incidence of C. difficile infection (CDI) has been rising worldwide with subsequent increases in morbidity, mortality, and health care costs.
H. Schäffler, Anne Breitrück
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.This prospective randomized trial demonstrated that a 4‐day regimen of sulbactam/ampicillin significantly reduced the incidence of perineal wound infection (PWI) following abdominoperineal resection compared to a 1‐day cefmetazole regimen. This simple approach to antibiotic selection may be beneficial for preventing PWI.
Akitoshi Nankaku +12 more
wiley +1 more source
Infection Clostridium difficile as increasing epidemiological issue
Journal of Education, Health and Sport, 2017 Introduction: Clostridium difficile as an infectious agent of pseudomembranous enterocolitis, becomes more and more frequent problem among health facilities.
Maciej Rutkowski +3 more
doaj +3 more sources
A search for Clostridium difficile ribotypes 027 and 078 in Brazil
Brazilian Journal of Infectious Diseases, 2014 Toxigenic strains of Clostridium difficile may be disseminating. Here we prospectively screened patients with nosocomial diarrhoea in two hospitals in Brazil. To identify C.
Alexandre de Almeida Monteiro +4 more
doaj +1 more source
Evidence for antibiotic induced Clostridium perfringens diarrhoea [PDF]
, 2001 Clostridium difficile is a well documented cause of antibiotic associated diarrhoea in hospitalised patients, but may account for only approximately 20% of all cases.
Modi, N., Wilcox, M.H.
core +1 more source
Diarrhoea caused by Clostridium difficile in patients with postoperative subhepatic abscess [PDF]
, 2008 Background. Toxigenic strains of Clostridium difficile in the majority of cases cause disease of the intestinal tract of hospitalized patients. For a long time, Clostridium difficile was considered to produce both types of toxins (A+/B+ strain), however,
Kocić Branislava, Stojanović Predrag
core +1 more source
Porcine Colostrum Protects the IPEC-J2 Cells and Piglet Colon Epithelium against Clostridioides (syn. Clostridium) difficile Toxin-Induced Effects [PDF]
, 2020 Clostridioides difficile toxins are one of the main causative agents for the clinical symptoms observed during C. difficile infection in piglets. Porcine milk has been shown to strengthen the epithelial barrier function in the piglet’s intestine and may ...
Grześkowiak, Łukasz +7 more
core +1 more source